Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

As pharmacists, we have two types of customers — the patient and the payer — and both want better value for their investment, expecting reduced healthcare costs and improved clinical outcomes. In order to stay competit...

View Blog Post
Blog Post

Bacterial resistance to commonly used empiric therapy in head and neck infections is frequently reported. Conventional treatment for these types of infections usually has been high dose penicillins, or clindamycin in patients with...

View Blog Post
Blog Post

September is Sepsis Awareness Month. Follow events and discussions at #SAM2017. Accordin...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up